1. A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation. Issue 12 (30th October 2018) Authors: Castroviejo‐Bermejo, Marta; Cruz, Cristina; Llop‐Guevara, Alba; Gutiérrez‐Enríquez, Sara; Ducy, Mandy; Ibrahim, Yasir Hussein; Gris‐Oliver, Albert; Pellegrino, Benedetta; Bruna, Alejandra; Guzmán, Marta; Rodríguez, Olga; Grueso, Judit; Bonache, Sandra; Moles‐Fernández, Alejandro; Villacampa, Guil... Journal: EMBO molecular medicine Issue: Volume 10:Issue 12(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation. Issue 12 (30th October 2018) Authors: Castroviejo‐Bermejo, Marta; Cruz, Cristina; Llop‐Guevara, Alba; Gutiérrez‐Enríquez, Sara; Ducy, Mandy; Ibrahim, Yasir Hussein; Gris‐Oliver, Albert; Pellegrino, Benedetta; Bruna, Alejandra; Guzmán, Marta; Rodríguez, Olga; Grueso, Judit; Bonache, Sandra; Moles‐Fernández, Alejandro; Villacampa, Guil... Journal: EMBO molecular medicine Issue: Volume 10:Issue 12(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation. Issue 12 (30th October 2018) Authors: Castroviejo‐Bermejo, Marta; Cruz, Cristina; Llop‐Guevara, Alba; Gutiérrez‐Enríquez, Sara; Ducy, Mandy; Ibrahim, Yasir Hussein; Gris‐Oliver, Albert; Pellegrino, Benedetta; Bruna, Alejandra; Guzmán, Marta; Rodríguez, Olga; Grueso, Judit; Bonache, Sandra; Moles‐Fernández, Alejandro; Villacampa, Guil... Journal: EMBO molecular medicine Issue: Volume 10:Issue 12(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗